In 50 adults with major depressive disorder and suicidal ideation given one ketamine infusion, 4 weeks of low-dose sublingual buprenorphine reduced SSI scores more than placebo (mean change −11.6 vs −6.3; n=45 analysed). Depression scores did not differ.
RCTn = 50
Tucciarone et al. Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial